Literature DB >> 31836039

Role of Renal Hypoxia in the Progression From Acute Kidney Injury to Chronic Kidney Disease.

Md Mahbub Ullah1, David P Basile2.   

Abstract

Over the past 20 years, there has been an increased appreciation of the long-term sequelae of acute kidney injury (AKI) and the potential development of chronic kidney disease (CKD). Several pathophysiologic features have been proposed to mediate AKI to CKD progression including maladaptive alterations in tubular, interstitial, inflammatory, and vascular cells. These alterations likely interact to culminate in the progression to CKD. In this article we focus primarily on evidence of vascular rarefaction secondary to AKI, and the potential mechanisms by which rarefaction occurs in relation to other alterations in tubular and interstitial compartments. We further focus on the potential that rarefaction contributes to renal hypoxia. Consideration of the role of hypoxia in AKI to CKD transition focuses on experimental evidence of persistent renal hypoxia after AKI and experimental maneuvers to evaluate the influence of hypoxia, per se, in progressive disease. Finally, consideration of methods to evaluate hypoxia in patients is provided with the suggestion that noninvasive measurement of renal hypoxia may provide insight into progression in post-AKI patients.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibrosis; inflammation; peritubular capillaries; renal hypoxia

Year:  2019        PMID: 31836039     DOI: 10.1016/j.semnephrol.2019.10.006

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  13 in total

Review 1.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

2.  Novel Protein Therapeutics Created Using the Elastin-Like Polypeptide Platform.

Authors:  Gene L Bidwell
Journal:  Physiology (Bethesda)       Date:  2021-09-06

Review 3.  Orai1: A New Therapeutic Target for the Acute Kidney Injury-to-Chronic Kidney Disease Transition.

Authors:  David P Basile; Jason A Collett
Journal:  Nephron       Date:  2021-08-25       Impact factor: 3.457

4.  Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis.

Authors:  Nattawat Klomjit; Xiang-Yang Zhu; Alfonso Eirin; Aditya S Pawar; Sabena M Conley; Amrutesh S Puranik; Christopher M Ferguson; Seo Rin Kim; Hui Tang; Kyra L Jordan; Ishran M Saadiq; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2022-09-22       Impact factor: 7.186

Review 5.  Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside.

Authors:  Sungjin Chung; Gheun-Ho Kim
Journal:  Life (Basel)       Date:  2021-04-25

6.  Roles of SIRT6 in kidney disease: a novel therapeutic target.

Authors:  Xueyan Yang; Jun Feng; Wei Liang; Zijing Zhu; Zhaowei Chen; Jijia Hu; Dingping Yang; Guohua Ding
Journal:  Cell Mol Life Sci       Date:  2021-12-24       Impact factor: 9.261

7.  T helper 17 cells in the pathophysiology of acute and chronic kidney disease.

Authors:  David P Basile; Md Mahbub Ullah; Jason A Collet; Purvi Mehrotra
Journal:  Kidney Res Clin Pract       Date:  2021-03-23

8.  Changes in the Expression of Renal Brush Border Membrane N-Glycome in Model Rats with Chronic Kidney Diseases.

Authors:  Aiying Yu; Jingfu Zhao; Shiv Pratap S Yadav; Bruce A Molitoris; Mark C Wagner; Yehia Mechref
Journal:  Biomolecules       Date:  2021-11-11

Review 9.  Therapies Targeting Epigenetic Alterations in Acute Kidney Injury-to-Chronic Kidney Disease Transition.

Authors:  Fumiaki Tanemoto; Imari Mimura
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-20

10.  Inhibition of IRE1/JNK pathway in HK-2 cells subjected to hypoxia-reoxygenation attenuates mesangial cells-derived extracellular matrix production.

Authors:  Yan Liang; Lulu Liang; Zhenjie Liu; Yingzi Wang; Xiubing Dong; Lingyun Qu; Rong Gou; Yulin Wang; Qian Wang; Zhangsuo Liu; Lin Tang
Journal:  J Cell Mol Med       Date:  2020-10-11       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.